List of articles in "Drug" category - Page 61

Sarilumab is a human monoclonal antibody against the interleukin-6 receptor.Regeneron and Sanofi are currently co-developing the drug for the treatment of rheumatoid arthritis for which it is in phase III […]

Rilotumumab is a human monoclonal antibody designed for the treatment of solid tumors.Rilotumumab was developed by Amgen Inc.

Tabalumab (LY 2127399) is an anti-B-cell activating factor (BAFF) human monoclonal antibody designed for the treatment of autoimmune diseases and B cell malignancies.Tabalumab was developed by Eli Lilly and Company.A […]

Fezakinumab is a human monoclonal antibody against interleukin-22 designed for the treatment of psoriasis and rheumatoid arthritis.Wyeth discovered and initially developed the drug and clinical development continued after that company […]

Sifalimumab is a human monoclonal antibody designed for the treatment of SLE dermatomyositis and polymyositis.Sifalimumab was developed by MedImmune.

Urelumab (ue rel’ ue mab; also known as BMS-663513 and anti-4-1BB antibody) is a fully human IgG4 monoclonal antibody developed by Bristol-Myers Squibb for the treatment of cancer and solid […]

Tralokinumab is a human monoclonal antibody which targets the cytokine interleukin 13 and is designed for the treatment of asthma and inflammatory diseases.Tralokinumab was discovered by Cambridge Antibody Technology as […]

Teprotumumab is a human monoclonal antibody designed for the treatment of solid and hematologic tumors.Teprotumumab was developed by Roche.

Sirukumab (CNTO 136) is a human monoclonal antibody designed for the treatment of rheumatoid arthritis.Sirukumab is currently under development by Johnson & Johnson’s subsidiary Centocor.

Secukinumab is a human monoclonal antibody designed for the treatments of uveitis rheumatoid arthritis and psoriasis. It targets member A from the cytokine family of interleukin 17.Secukinumab was developed by […]